The influence of TP53 on other pathways is further exemplified by findings from a study conducted across 854 pHGG tumor samples revealing a significant association between the presence of TP53 mutations and high somatic structural variant (SSV) burden involving large scale genomic alterations (188). This evidence concerns the gene TP53 and neoplasm.